Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma

NCT02436707

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View Trial Details
Active, Not Recruiting

Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies

NCT03932331

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Changchun, China
View all 23 locations
View Trial Details
Active, Not Recruiting

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

NCT05020678

Conditions
Aggressive Lymphoma, B-cell Acute Lymphoblastic Leukemia, Blood Protein Disorders, +43 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • The Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Institute of Haematology, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • St. Vincent's Hospital Sydney, New South Wales, Australia
View Trial Details
Active, Not Recruiting

Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease

NCT04166565

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Extramedullary Plasmacytoma, +13 more
Locations
  • University of Athens Athens, Greece
  • Anticancer Hospital of Thessaloniki Thessaloniki, Greece
  • University of Bologna Bologna, Italy
  • Univerity of Turin Torino, Italy
View Trial Details
Active, Not Recruiting

A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma

NCT05888493

Conditions
Disease Attributes, Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, +12 more
Locations
  • Novartis Investigative Site Camperdown, New South Wales, Australia
  • Novartis Investigative Site Clayton, Victoria, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Nedlands, Western Australia, Australia
View all 30 locations
View Trial Details

Related conditions